Evaluation of a Viscosity/Elasticity Assay (ReoRox®) for Assessment of Platelet Storage Lesion and Fibrinogen Dependent Coagulation

The impact storage has on function of platelet concentrates is not completely known, although some factors have been discovered and measures have been taken to counteract them, such as adding platelet additive solution. There are several methods for analysing platelet function. In this study, the ai...

Full description

Bibliographic Details
Main Author: Guðjónsdóttir, Erla
Format: Others
Language:Swedish
Published: Uppsala universitet, Institutionen för kvinnors och barns hälsa 2016
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-297956
id ndltd-UPSALLA1-oai-DiVA.org-uu-297956
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-uu-2979562017-09-05T05:14:48ZEvaluation of a Viscosity/Elasticity Assay (ReoRox®) for Assessment of Platelet Storage Lesion and Fibrinogen Dependent CoagulationsweGuðjónsdóttir, ErlaUppsala universitet, Institutionen för kvinnors och barns hälsa2016Thrombine receptor activator peptide (TRAP)aggregabilityfree oscillation rheometry (FOR)fibrinolysisblood clot.Biomedical Laboratory Science/TechnologyBiomedicinsk laboratorievetenskap/teknologiThe impact storage has on function of platelet concentrates is not completely known, although some factors have been discovered and measures have been taken to counteract them, such as adding platelet additive solution. There are several methods for analysing platelet function. In this study, the aim was to analyse change of platelet function in platelet concentrates over time and to see what effect fibrogen has on the coagulation. A technique using free oscillation rheometry (FOR), ReoRox®, was used to analyse function in platelet concentrates, both over time and after addition of fibrinogen. The platelets were analyzed at a concentration of 800 x109 Ptl/L and activated with thrombin receptor antigen peptide (TRAP). For fibrinogen efect analysis, four different concentrations were used, 10 g/L, 2,25 g/L, 1,0 g/L and 0,1 g/L. The results showed no statistically significant change in the function over time. However an increase in elasticity and decrease in the decline of elasticity could be seen. While analysing the platelets with fibrinogen it showed that up to 2,25 g/L the aggregation increased, while it decreased significantly at 10 g/L. In conclusion, the platelet concentrates retained a good clotting function from day one to day seven of storage, while the clot became stronger and fibrinolysis decreased. Fibrinogen proved important for coagulation, however a too high concentration inhibits coagulation. Student thesisinfo:eu-repo/semantics/bachelorThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-297956application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language Swedish
format Others
sources NDLTD
topic Thrombine receptor activator peptide (TRAP)
aggregability
free oscillation rheometry (FOR)
fibrinolysis
blood clot.
Biomedical Laboratory Science/Technology
Biomedicinsk laboratorievetenskap/teknologi
spellingShingle Thrombine receptor activator peptide (TRAP)
aggregability
free oscillation rheometry (FOR)
fibrinolysis
blood clot.
Biomedical Laboratory Science/Technology
Biomedicinsk laboratorievetenskap/teknologi
Guðjónsdóttir, Erla
Evaluation of a Viscosity/Elasticity Assay (ReoRox®) for Assessment of Platelet Storage Lesion and Fibrinogen Dependent Coagulation
description The impact storage has on function of platelet concentrates is not completely known, although some factors have been discovered and measures have been taken to counteract them, such as adding platelet additive solution. There are several methods for analysing platelet function. In this study, the aim was to analyse change of platelet function in platelet concentrates over time and to see what effect fibrogen has on the coagulation. A technique using free oscillation rheometry (FOR), ReoRox®, was used to analyse function in platelet concentrates, both over time and after addition of fibrinogen. The platelets were analyzed at a concentration of 800 x109 Ptl/L and activated with thrombin receptor antigen peptide (TRAP). For fibrinogen efect analysis, four different concentrations were used, 10 g/L, 2,25 g/L, 1,0 g/L and 0,1 g/L. The results showed no statistically significant change in the function over time. However an increase in elasticity and decrease in the decline of elasticity could be seen. While analysing the platelets with fibrinogen it showed that up to 2,25 g/L the aggregation increased, while it decreased significantly at 10 g/L. In conclusion, the platelet concentrates retained a good clotting function from day one to day seven of storage, while the clot became stronger and fibrinolysis decreased. Fibrinogen proved important for coagulation, however a too high concentration inhibits coagulation.
author Guðjónsdóttir, Erla
author_facet Guðjónsdóttir, Erla
author_sort Guðjónsdóttir, Erla
title Evaluation of a Viscosity/Elasticity Assay (ReoRox®) for Assessment of Platelet Storage Lesion and Fibrinogen Dependent Coagulation
title_short Evaluation of a Viscosity/Elasticity Assay (ReoRox®) for Assessment of Platelet Storage Lesion and Fibrinogen Dependent Coagulation
title_full Evaluation of a Viscosity/Elasticity Assay (ReoRox®) for Assessment of Platelet Storage Lesion and Fibrinogen Dependent Coagulation
title_fullStr Evaluation of a Viscosity/Elasticity Assay (ReoRox®) for Assessment of Platelet Storage Lesion and Fibrinogen Dependent Coagulation
title_full_unstemmed Evaluation of a Viscosity/Elasticity Assay (ReoRox®) for Assessment of Platelet Storage Lesion and Fibrinogen Dependent Coagulation
title_sort evaluation of a viscosity/elasticity assay (reorox®) for assessment of platelet storage lesion and fibrinogen dependent coagulation
publisher Uppsala universitet, Institutionen för kvinnors och barns hälsa
publishDate 2016
url http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-297956
work_keys_str_mv AT guðjonsdottirerla evaluationofaviscosityelasticityassayreoroxforassessmentofplateletstoragelesionandfibrinogendependentcoagulation
_version_ 1718527542777872384